FASLG and liver disorder: Further longitudinal studies are warranted in HBV-and HBV/HIV-infected patients to better understand the role sFas and sFasL are playing in HBV-mediated liver disease and whether there is any prognostic value in monitoring sFas and sFasL levels [46, 62, 68].